Shenzhen Huian Bioscitech Co., Ltd. was established in April 2004. Headquartered in Shenzhen—a city of innovation and dreams—the company specializes in the development, production, sales, and service of in vitro diagnostic medical devices.

l A professional and efficient technical and expert team;

l Comprehensive facilities for office, production, R&D, sales, warehousing, and quality assurance;

l Complete industry certifications, including NMPA GMP certification and SGS ISO 13485:2016 accreditation;

l Recognized as a National High-Tech Enterprise, a Shenzhen Specialized, Refined, Unique, and New SME, and a Shenzhen Innovative SME.

Core Products

The company primarily develops and manufactures the "Q-yianni®" series of point-of-care testing (POCT) products. It offers 45 CE-certified products and 31 NMPA-approved products, covering rapid diagnostics for infectious diseases, infections, cardiac conditions, digestive tract disorders, gynecological diseases, autoimmune diseases, and coagulation disorders.

Core Technologies

The company employs monoclonal antibody technology, colloidal gold technology, double-antibody sandwich technology, and lateral flow immunoassay technology, ultimately forming its core Gold Immunoassay Lateral Flow Assay (GILFA) platform.

Business Presence

The company operates across 32 provinces, municipalities, autonomous regions, and direct-administered municipalities in China, as well as in 21 countries and regions overseas. It is committed to providing high-quality products and efficient services to enable rapid diagnosis and treatment for patients worldwide, alleviating suffering and promoting healthier lives.